Skip to content

Internet Buzzing About Approval Of NPS Pharmaceuticals’ Orphan Drug Gattex (Teduglutide) For Short Bowel Syndrome

October 17, 2012

       On Tuesday, October 16, 2012, NPS Pharmaceuticals announces that orphan drug Gattex (Teduglutide) receives a unanimous recommendation for approval from the FDA’s Gastrointestinal Drugs Advisory Committee for treatment of adults with Short Bowel Syndrome (SBS). Now everyone waits for a decision from the FDA, with the PDUFA date  of December 30, 2012. 

        The following is what the Internet is Buzzing about : 

1)  Reuters.com October 16, 2012 article titled, “FDA advisers back NPS’s drug for short bowel syndrome”  

2)  SeekingAlpha.com October 17, 2012 article titled,”NPS Pharmaceuticals’ CEO discusses Gattex Update (Transcript)”  

 3)  MedReps.com October 16, 2012 article titled,”FDA says NPS’s bowel drugs need no restrictions for future pharmaceutical sales”  

4)  PharmaTimes.com October 17, 2012 article titled,”FDA panel recommends NPS bowel drug Gattex”  

5)  FinancialPost.com October 16, 2012 article titled,”FDA Advisory Committee Unanimously Recommends Approval of Gattex (Teduglutide) For Adults With Short Bowel Syndrome (SBS)”

 Copyright  © 2012-2013, Ann-Teresa Cusenza and Orphan Druganaut Blog.  All rights reserved.

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: